ArticleOncotarget2017
Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.
Bin Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncotarget2017
Bin Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.